ElisaSorrenti Università della Svizzera ItalianaSwitzerland

I am a postdoctoral researcher at the Host–Microbiota Dynamics Laboratory, Institute for Translational Research (USI-EOC, Switzerland). I obtained my PhD in Biomedical Sciences from Università della Svizzera italiana, where I focused on the interplay between gut microbiota and tumor-associated neutrophils in colorectal cancer. My research interests include tumor immunology, cancer–microbiota interactions, and mechanisms of tumor progression.

Wednesday 10 June 2026

Time	Session

11:35 13:10	Symposium: Microbiome Marisol S.Soengas Co-Chair Spanish National Cancer Research Center (CNIO)Spain Decoding host-microbiome interactions in cancer immunity. Killing cancer with a gut instinct EvangelosGiampazolias Speaker University of ManchesterUnited Kingdom Proffered Paper: Intra-tumoral microbiota and host genotype cooperatively shape neutrophil cytotoxic functions in patients with colorectal cancer EACR26-0130 EACR26-0130 ElisaSorrenti Oral Presenter Università della Svizzera ItalianaSwitzerland The microbiota in cancer treatment efficacy MariaRescigno Speaker CeMMAustria Proffered Paper: Immune Checkpoint Inhibitor Therapy Efficacy and Toxicity Is Associated with Distinct Gut Microbiome–Driven Inflammatory Profiles EACR26-1103 EACR26-1103 Merelvan Gogh Oral Presenter UMC UtrechtNetherlands Covalent targeting of the proteasome regulator PSME4 reprograms tumor inflammation YifatMerbl Speaker The Merbl LabIsrael Room F1+2+3

Time

Session

11:35

13:10

Symposium: Microbiome

Marisol S.Soengas Co-Chair Spanish National Cancer Research Center (CNIO)Spain

Decoding host-microbiome interactions in cancer immunity. Killing cancer with a gut instinct

EvangelosGiampazolias Speaker University of ManchesterUnited Kingdom
Proffered Paper: Intra-tumoral microbiota and host genotype cooperatively shape neutrophil cytotoxic functions in patients with colorectal cancer

EACR26-0130

EACR26-0130

ElisaSorrenti Oral Presenter Università della Svizzera ItalianaSwitzerland
The microbiota in cancer treatment efficacy

MariaRescigno Speaker CeMMAustria
Proffered Paper: Immune Checkpoint Inhibitor Therapy Efficacy and Toxicity Is Associated with Distinct Gut Microbiome–Driven Inflammatory Profiles

EACR26-1103

EACR26-1103

Merelvan Gogh Oral Presenter UMC UtrechtNetherlands
Covalent targeting of the proteasome regulator PSME4 reprograms tumor inflammation

YifatMerbl Speaker The Merbl LabIsrael

Room F1+2+3